Marinova is an Australian biotechnology company dedicated to the development and production of high purity seaweed extracts for the betterment of human health. Marinova specialises in the research, development and manufacture of fucoidan compounds – highly bioactive polysaccharides derived from select species of brown seaweed.
As the global leader in fucoidan science, Marinova is the supplier of choice to world-renowned research institutions. The company's reputation is built on the unrivalled quality and efficacy of its bioactive fucoidan extracts and two decades of rigorous scientific investigation.
Marinova is home to the range of unique Maritech® organic fucoidan extracts - high purity fucoidans developed specifically for nutritional, cosmetic and animal health applications.
No one knows fucoidan like Marinova – the fucoidan experts.
| Sales markets | Asia; Australia; Eastern Europe; North America; Western Europe |
|---|---|
| Primary business activity | Raw Material Supplier |
| Affiliated categories: | Fucoidan |Other Algae |Other Bioactives More |

7 Oct 2025
1 Sep 2025
19 Jun 2025
A new study suggests supplementation with the marine polysaccharide fucoidan may provide significant gut health benefits.
Read more9 Jan 2025
The sustainability credentials of biotechnology company Marinova have been recognised across Australia with two high profile business awards.
Read more